Skip to main content

Johnson & Johnson says it can produce 20M doses of COVID-19 vaccine by late March

Johnson & Johnson said Tuesday it can produce 20 million doses of the single-shot coronavirus vaccine by late March and has applied for emergency authorization by the Food and Drug Administration.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.